Diagnosing breast lesions by fine needle aspiration cytology or core biopsy: which is better?
Systematic review of aromatase inhibitors in the first-line treatment for hormone sensitive advanced or metastatic breast cancer
The cognitive effects of chemotherapy in post-menopausal breast cancer patients: a controlled longitudinal study
The fog hasn't lifted on “chemobrain” yet: ongoing uncertainty regarding the effects of chemotherapy and breast cancer on cognition
GM-CSF is one of the main breast tumor-derived soluble factors involved in the differentiation of CD11b-Gr1- bone marrow progenitor cells into myeloid-derived suppressor cells
GPR30 and estrogen receptor expression: new insights into hormone dependence of inflammatory breast cancer
Gli1 promotes cell survival and is predictive of a poor outcome in ERα-negative breast cancer
A unique proteolytic fragment of alpha1-antitrypsin is elevated in ductal fluid of breast cancer patient
Role of GPR30 in the mechanisms of tamoxifen resistance in breast cancer MCF-7 cells
Prognostic impact of ALDH1 in breast cancer: a story of stem cells and tumor microenvironment
Is ALDH1 a good method for definition of breast cancer stem cells?
Cyclin D1 is a direct target of JAG1-mediated Notch signaling in breast cancer
Concordant HER2 status between metastatic breast cancer cells in CSF and primary breast cancer tissue
Concordance of HER2 in primary tumor and leptomeningeal metastases: now what?
Five common single nucleotide polymorphisms in the PALB2 gene and susceptibility to breast cancer in eastern Chinese population
Reciprocal regulation of ZEB1 and AR in triple negative breast cancer cells
Molecular predictors of efficacy of adjuvant weekly paclitaxel in early breast cancer
Adjuvant chemotherapy is not for everyone
CEF is superior to CMF for tumours with TOP2A aberrations: a Subpopulation Treatment Effect Pattern Plot (STEPP) analysis on Danish Breast Cancer Cooperative Group Study 89D
Re-searching anthracycline therapy
Triple negative breast cancer in Korea-distinct biology with different impact of prognostic factors on survival
DNA repair signature is associated with anthracycline response in triple negative breast cancer patients
Weekly paclitaxel improved pathologic response of primary chemotherapy compared with standard 3 weeks schedule in primary breast cancer
Associations between XPD polymorphisms and risk of breast cancer: a meta-analysis
Methionine synthase A2756G polymorphism and breast cancer risk: a meta-analysis involving 18,953 subjects
XRCC2 Arg188His polymorphism is not directly associated with breast cancer risk: evidence from 37,369 subjects
The association between ERCC2 Asp312Asn polymorphism and breast cancer risk: a meta-analysis involving 22,766 subjects
Global breast cancer seasonality
Mammographic density does not differ between unaffected BRCA1/2 mutation carriers and women at low-to-average risk of breast cancer
Population-based survival-cure analysis of ER-negative breast cancer
COMT Val158Met polymorphism and breast cancer risk: evidence from 26 case-control studies
Metformin and rapamycin have distinct effects on the AKT pathway and proliferation in breast cancer cells
The use of FDG-PET in assessing axillary lymph node status in breast cancer: a systematic review and meta-analysis of the literature
Comparative disease pattern of a patient with a novel BRCA2 truncation and knockout models for BRCA2
Treatment of breast cancer through the application of irreversible electroporation using a novel minimally invasive single needle electrode
Adjuvant!© Online estimation of chemotherapy effectiveness when added to ovarian function suppression plus tamoxifen for premenopausal women with estrogen-receptor-positive breast cancer
Is there a role for ovarian function suppression in operable breast cancer?